ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study is evaluating the safety, pharmacokinetics (PK), pharmacodynamics (PD) and
efficacy of ACP-196 in subjects with Rheumatoid Arthritis on background Methotrexate.